Fig. 9From: The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicitySchematic diagram of the mechanism of propranolol in the treatment for ATO-induced cardiotoxicityBack to article page